CytoMed Therapeutics Limited (GDTC)
NASDAQ: GDTC · Real-Time Price · USD
2.430
-0.250 (-9.33%)
At close: Oct 23, 2025, 4:00 PM EDT
2.310
-0.120 (-4.94%)
After-hours: Oct 23, 2025, 7:18 PM EDT

CytoMed Therapeutics Revenue

CytoMed Therapeutics had revenue of 450.69K SGD in the half year ending June 30, 2025, with 58.57% growth. This brings the company's revenue in the last twelve months to 729.88K, up 63.03% year-over-year. In the year 2024, CytoMed Therapeutics had annual revenue of 503.37K, down -0.86%.

Revenue (ttm)
729.88K SGD
Revenue Growth
+63.03%
P/S Ratio
53.96
Revenue / Employee
16,974 SGD
Employees
43
Market Cap
28.04M USD

Revenue Chart

* This company reports financials in SGD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024503.37K-4.36K-0.86%
Dec 31, 2023507.74K143.82K39.52%
Dec 31, 2022363.91K250.07K219.67%
Dec 31, 2021113.84K54.37K91.43%
Dec 31, 202059.47K--
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group422.82B
Johnson & Johnson92.15B
Merck & Co.63.62B
AbbVie58.33B
AstraZeneca56.50B
Novartis AG55.19B
Eli Lilly and Company53.26B
Novo Nordisk49.11B
Revenue Rankings